Biomarker: F234-IgE Vanilla

Overview

F234-IgE Vanilla measures serum immunoglobulin E (IgE) antibodies that recognize vanilla, generally derived from Vanilla planifolia. Specific IgE can indicate immune sensitization, but a positive result does not by itself confirm symptomatic food allergy or predict reaction severity. Vanilla-associated reactions are uncommon, and published clinical evidence includes both suspected immediate reactions and delayed contact dermatitis; contact reactions may not be detected by serum-specific IgE testing. The test is clinically useful when interpreted with the exposure history and symptoms, particularly when skin testing is unsuitable or additional evidence of sensitization is needed.

Clinical Use Cases

Evaluating suspected IgE-mediated reactions after eating or being exposed to vanilla-containing foods.
Supporting the assessment of possible food allergy alongside the clinical history and, when appropriate, skin-prick testing or a medically supervised oral food challenge.
Investigating sensitization when skin testing is contraindicated, impractical, or affected by medications.
Assessing possible reactions to vanilla-containing flavorings, foods, or products when the exposure is clinically relevant.
Distinguishing possible immediate IgE sensitization from suspected allergic contact dermatitis, which is evaluated with patch testing rather than serum-specific IgE testing.

Specimen Types

Venous blood serum is the usual specimen for allergen-specific IgE measurement.
Plasma may be accepted by some assay systems, subject to the laboratory’s specimen requirements.

Measurement Methods

Fluorescence-based solid-phase immunoassay, such as ImmunoCAP, in which allergen-specific IgE binds to immobilized allergen and is detected with labeled anti-human IgE.
Enzyme-linked immunosorbent or other solid-phase immunoassays using allergen-bound surfaces and labeled anti-IgE antibodies.
Results are generally reported quantitatively or semiquantitatively in kU/L, with interpretation categories determined by the assay and laboratory.

Test Preparation and Influencing Factors

Fasting is generally not required for an allergy blood test.
Tell the healthcare professional about all medications and supplements. Do not stop prescribed medicines unless instructed.
Antihistamines usually do not interfere with blood-based specific-IgE testing, although they can affect skin-prick testing; follow the ordering clinician’s instructions.
Total IgE concentration, age, immune status, assay characteristics, and the laboratory’s reporting threshold may influence interpretation.
A detectable F234-specific IgE result indicates sensitization, not necessarily clinical allergy.
The magnitude of specific IgE does not reliably predict reaction severity.
A negative result does not exclude a non-IgE-mediated reaction or allergic contact dermatitis. Patch testing is the reference test for allergic contact dermatitis.
Results should be interpreted with the timing, reproducibility, and nature of symptoms after exposure. Medically supervised oral food challenge may be needed when the diagnosis remains uncertain.